Jana Hof - Concepedia

Author

Jana Hof

Also Known As

J Hof, J M von Hof, J. Hof, J. Marian Von Hof, J. Marian von Hof, J. Marian von Hof, J. Marian von Hof, Jana Hof, von Hof, J.M.

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin University of Göttingen Heidelberg University German Cancer Research Center Deutschen Konsortium für Translationale Krebsforschung

About

Jana Hof is an author at Charité - Universitätsmedizin Berlin specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	580
2	Natural Sciences	4	4	77
3	Biochemistry	4	4	108
4	Engineering	2	2	88
5	Health Sciences	1	1	41

Jana Hof

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL Gannie Tzoneva, Arianne Pérez-García, Zachary Carpenter, Nature Medicine Genome InstabilitySomatic VariantMedicineMolecular BiologyCancer Genetics	2013	337
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition Julie Irving, Elizabeth Matheson, Lynne Minto, Blood	2014	248
Mutations and Deletions of the <i>TP53</i> Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia Jana Hof, Stefanie Groeneveld‐Krentz, Claudia van Schewick, Journal of Clinical Oncology	2011	203
Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases Jana Hof, Marieke W.J.L.A.E. Wertenbroek, Paul Peeters, British journal of surgery	2016	140
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia Paulina Richter‐Pechańska, Joachim B. Kunz, Jana Hof, Blood Cancer Journal	2017	89
Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia Stefanie Groeneveld‐Krentz, Jana Hof, A Mendioroz, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderPrognostic ValueHematology	2012	87
Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation Joachim B. Kunz, Tobias Rausch, Obul Reddy Bandapalli, Haematologica EngineeringMixed-phenotype Acute LeukemiaGeneticsRelapse-specific ChangesEpigenetics	2015	78
High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse Shabnam Shalapour, Jana Hof, Renate Kirschner‐Schwabe, Haematologica	2011	75
Glycosidic Prodrugs of Highly Potent Bifunctional Duocarmycin Derivatives for Selective Treatment of Cancer Lutz F. Tietze, Jana Hof, Michael Müller, Angewandte Chemie International Edition Pharmaceutical ScienceChemoprevention StrategyGlycobiologyPharmacotherapyMedicinal Chemistry	2010	57
A Concise, Stereocontrolled Total Synthesis of Rippertenol Scott A. Snyder, Daniel A. Wespe, Jana Hof Journal of the American Chemical Society	2011	46

Page 1